미국의 소화기과 외래 수술 센터 시장 규모, 점유율, 동향 분석 보고서 : 소유별, 부문별 예측(2024-2030년)

U.S. Gastroenterology Ambulatory Surgery Centers Market Growth & Trends:

The U.S. gastroenterology ambulatory surgery center market size is anticipated to reach USD 9.78 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2024 to 2030. The growth can be attributed to cost-efficiency, improved patient outcomes, and patient convenience provided by the ambulatory surgery centers. In addition, factors such as rising prevalence of digestive diseases and growing geriatric population are expected to fuel the growth.

Establishment and maintenance of hospitals and other healthcare settings are capital-intensive. In addition, high cost of hospitalization associated with inpatient admission has led to increased patient preference for outpatient facilities over hospital visits. The number of ambulatory surgery centers (ASCs) in U.S. has witnessed a surge in the last few years in order to fulfill the growing demand for alternate surgical facilities. Currently, there are more than 9,280 ASCs in U.S. with highest concentration in California, Florida, and Texas.

The other segment includes ASCs owned by various joint ventures such as physician-hospital, physician-hospital-corporate, and physician-corporate gastroenterology. The physician-hospital joint-venture ASCs are gaining traction due to better patient outcomes, enhanced productivity, and ownership interest.

The rising number of partnerships and acquisitions is a key factor expected to drive the growth of the market. In February 2019, SurgCenter Development entered into an agreement with Surgery Partners to develop new ambulatory surgery centers.

Key industry participants among the service provider include Envision Healthcare Corporation; Tenet Healthcare Corporation; Surgery Partners; Community Health Systems, Inc. (CHS); Universal Health Service (UHS); Hospital Corporation of America (HCA); Surgery Care Affiliates (SCA); SurgCenter Development; Covenant Surgical Partners; and Regent Surgical Health.

U.S. Gastroenterology Ambulatory Surgery Centers Market Report Highlights:

• The freestanding ownership segment accounted for the highest market share in 2023 owing to maximum professional control over clinical environment, high profitability, and quality of care delivered to patients.
• High government expenditure for the development of ambulatory surgery centers to reduce treatment costs and increase accessibility along with better reimbursement policies for procedures performed at ASC are driving the market growth.
• Corporation-owned ownership is expected to grow at a CAGR of 5.4% over the projected years.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Gastroenterology Ambulatory Surgery Centers Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. U.S. Gastroenterology Ambulatory Surgery Centers Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Hospital-affiliated
  • 4.3.1. Hospital-affiliated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Freestanding
  • 4.4.1. Freestanding Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Corporation-owned
  • 4.5.1. Corporation-owned Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis by Key Market Participants
• 5.2. Company Categorization
• 5.3. Company Heat Map Analysis
• 5.4. Company Profiles
  • 5.4.1. TH Medical.
    • 5.4.1.1. Participant's Overview
    • 5.4.1.2. Financial Performance
    • 5.4.1.3. Product Benchmarking
    • 5.4.1.4. Recent Developments/ Strategic Initiatives
  • 5.4.2. GE Healthcare
    • 5.4.2.1. Participant's Overview
    • 5.4.2.2. Financial Performance
    • 5.4.2.3. Product Benchmarking
    • 5.4.2.4. Recent Developments/ Strategic Initiatives
  • 5.4.3. Universal Health Services, Inc.
    • 5.4.3.1. Participant's Overview
    • 5.4.3.2. Financial Performance
    • 5.4.3.3. Product Benchmarking
    • 5.4.3.4. Recent Developments/ Strategic Initiatives
  • 5.4.4. Covenant Physician Partners
    • 5.4.4.1. Participant's Overview
    • 5.4.4.2. Financial Performance
    • 5.4.4.3. Product Benchmarking
    • 5.4.4.4. Recent Developments/ Strategic Initiatives
  • 5.4.5. Regent Surgery
    • 5.4.5.1. Participant's Overview
    • 5.4.5.2. Financial Performance
    • 5.4.5.3. Product Benchmarking
    • 5.4.5.4. Recent Developments/ Strategic Initiatives
  • 5.4.6. Cardinal Health.
    • 5.4.6.1. Participant's Overview
    • 5.4.6.2. Financial Performance
    • 5.4.6.3. Product Benchmarking
    • 5.4.6.4. Recent Developments/ Strategic Initiatives
  • 5.4.7. Boston Scientific Corporation
    • 5.4.7.1. Participant's Overview
    • 5.4.7.2. Financial Performance
    • 5.4.7.3. Product Benchmarking
    • 5.4.7.4. Recent Developments/ Strategic Initiatives
  • 5.4.8. Olympus Corporation
    • 5.4.8.1. Participant's Overview
    • 5.4.8.2. Financial Performance
    • 5.4.8.3. Product Benchmarking
    • 5.4.8.4. Recent Developments/ Strategic Initiatives
  • 5.4.9. Koninklijke Philips NV
    • 5.4.9.1. Participant's Overview
    • 5.4.9.2. Financial Performance
    • 5.4.9.3. Product Benchmarking
    • 5.4.9.4. Recent Developments/ Strategic Initiatives
  • 5.4.10. Cook Medical
    • 5.4.10.1. Participant's Overview
    • 5.4.10.2. Financial Performance
    • 5.4.10.3. Product Benchmarking
    • 5.4.10.4. Recent Developments/ Strategic Initiatives